These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88 related articles for article (PubMed ID: 32191499)
1. Integrated Survival Analysis of mRNA and microRNA Signature of Patients with Breast Cancer Based on Cox Model. Zhang W; Zhang Y J Comput Biol; 2020 Sep; 27(9):1486-1494. PubMed ID: 32191499 [No Abstract] [Full Text] [Related]
2. An Integrative Model of miRNA and mRNA Expression Signature for Patients of Breast Invasive Carcinoma with Radiotherapy Prognosis. Bing Z; Tian J; Zhang J; Li X; Wang X; Yang K Cancer Biother Radiopharm; 2016 Sep; 31(7):253-60. PubMed ID: 27610468 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice. Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149 [TBL] [Abstract][Full Text] [Related]
4. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network. Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658 [TBL] [Abstract][Full Text] [Related]
5. Inferring miRNA sponge co-regulation of protein-protein interactions in human breast cancer. Zhang J; Le TD; Liu L; Li J BMC Bioinformatics; 2017 May; 18(1):243. PubMed ID: 28482794 [TBL] [Abstract][Full Text] [Related]
6. Regulatory network reconstruction of five essential microRNAs for survival analysis in breast cancer by integrating miRNA and mRNA expression datasets. He K; Li WX; Guan D; Gong M; Ye S; Fang Z; Huang JF; Lu A Funct Integr Genomics; 2019 Jul; 19(4):645-658. PubMed ID: 30859354 [TBL] [Abstract][Full Text] [Related]
7. Construction of an initial microRNA regulation network in breast invasive carcinoma by bioinformatics analysis. Yin Y; Shen C; Xie P; Cheng Z; Zhu Q Breast; 2016 Apr; 26():1-10. PubMed ID: 27017236 [TBL] [Abstract][Full Text] [Related]
8. Development and validation of GMI signature based random survival forest prognosis model to predict clinical outcome in acute myeloid leukemia. Shi M; Xu G BMC Med Genomics; 2019 Jun; 12(1):90. PubMed ID: 31242922 [TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of mRNA and miRNA profiles revealed the role of miR-193 and miR-210 as potential regulatory biomarkers in different molecular subtypes of breast cancer. Evangelista AF; Oliveira RJ; O Silva VA; D C Vieira RA; Reis RM; C Marques MM BMC Cancer; 2021 Jan; 21(1):76. PubMed ID: 33461524 [TBL] [Abstract][Full Text] [Related]
10. Construction of integrated microRNA and mRNA immune cell signatures to predict survival of patients with breast and ovarian cancer. Ray M; Ruffalo MM; Bar-Joseph Z Genes Chromosomes Cancer; 2019 Jan; 58(1):34-42. PubMed ID: 30285311 [TBL] [Abstract][Full Text] [Related]
11. Integrated Analysis of mRNA-miRNA-lncRNA ceRNA Network in Human HR+/Her-2- Breast Cancer and Triple Negative Breast Cancer. Jia X; Shi Y; Zhu Y; Meng W; He L; Jia Y; Tong Z J Comput Biol; 2020 Jul; 27(7):1055-1066. PubMed ID: 31647320 [TBL] [Abstract][Full Text] [Related]
12. Crucial microRNAs and genes of human primary breast cancer explored by microRNA-mRNA integrated analysis. Yang Y; Xing Y; Liang C; Hu L; Xu F; Chen Y Tumour Biol; 2015 Jul; 36(7):5571-9. PubMed ID: 25680412 [TBL] [Abstract][Full Text] [Related]
13. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines. Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600 [TBL] [Abstract][Full Text] [Related]
14. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer. Fan CN; Ma L; Liu N J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893 [TBL] [Abstract][Full Text] [Related]
15. Identification of a Combined RNA Prognostic Signature in Adenocarcinoma of the Lung. He SY; Xi WJ; Wang X; Xu CH; Cheng L; Liu SY; Meng QQ; Li B; Wang Y; Shi HB; Wang HJ; Wang ZZ Med Sci Monit; 2019 May; 25():3941-3956. PubMed ID: 31132294 [TBL] [Abstract][Full Text] [Related]
16. Clinical and RNA expression integrated signature for urothelial bladder cancer prognosis. Xiong J; Xiong K; Bing Z Cancer Biomark; 2018 Feb; 21(3):535-546. PubMed ID: 29226853 [TBL] [Abstract][Full Text] [Related]
17. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer. Bottai G; Diao L; Baggerly KA; Paladini L; Győrffy B; Raschioni C; Pusztai L; Calin GA; Santarpia L Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106823 [TBL] [Abstract][Full Text] [Related]
18. Prioritizing breast cancer subtype related miRNAs using miRNA-mRNA dysregulated relationships extracted from their dual expression profiling. Hua L; Zhou P; Li L; Liu H; Yang Z J Theor Biol; 2013 Aug; 331():1-11. PubMed ID: 23619378 [TBL] [Abstract][Full Text] [Related]
19. Integration of microRNA signatures of distinct mammary epithelial cell types with their gene expression and epigenetic portraits. Pal B; Chen Y; Bert A; Hu Y; Sheridan JM; Beck T; Shi W; Satterley K; Jamieson P; Goodall GJ; Lindeman GJ; Smyth GK; Visvader JE Breast Cancer Res; 2015 Jun; 17(1):85. PubMed ID: 26080807 [TBL] [Abstract][Full Text] [Related]
20. Integrated analysis of directly captured microRNA targets reveals the impact of microRNAs on mammalian transcriptome. Bjerke GA; Yi R RNA; 2020 Mar; 26(3):306-323. PubMed ID: 31900330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]